WESTBOROUGH, MA--(Marketwire - March 11, 2009) - IBC Life Sciences will hold its 4th Annual BioProcess International™ Analytical and Quality Summit in La Jolla, California on May 4-6, 2009.
The first day of the conference will feature a half day analytical and quality leadership keynote forum where attendees will hear analytical leadership perspectives from Amgen, Genentech, Genzyme and Human Genome Sciences. These keynote presentations will provide insight on how current trends in technology, regulatory expectations and new standards will impact a company's CMC development programs.
Keynote presentation topics:
-- Key Challenges and Trends in the Role of Analytics in
Biopharmaceutical Development
-- Regularity Expectations for QbD-Based Filings
-- Impact of Changing Regularity Landscape on Analytical Programs during
the Product Lifecycle
-- Whose Problem is Post-Translation Modifications? The Roles of
Discovery, Cell Culture and Chromatography in Understanding and Controlling
PTMs
This session will also include a panel discussion featuring director level speakers from Amgen, Genetech, Genzyme, Biogen Idec and Human Genome Sciences titled, "Current Trends in the Analytical and Quality Functions: How Can We Invest Wisely and Realize the Benefits of Next Generation Technologies and Approaches?"
This conference program is comprised of separate tracks dedicated to biophysical analysis, post-translational modifications and method validation -- with an additional track helping to tie these analytical fields to the need for improved product understanding associated with Quality by Design.
This multi-track format allows attendees to customize their conference experience based on personal job functions, responsibilities and the needs of their organization.
Writers and editors are encouraged to attend. For a press pass, please contact Dawn O'Connor at doconnor@ibcusa.com
About IBC Life Sciences
IBC Life Sciences is the worldwide leader in scientific, technological and
business conferences and courses for the life science industry. To develop
its programs, IBC actively researches the advancements, technologies and
trends impacting and driving the race for new drugs and therapies. No
other organization can make claim to the breadth and quality that IBC Life
Sciences delivers in each event giving the company recognition around the
globe for quality, service and value. For more information, visit:
http://www.IBCLifeSciences.com.
